Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minnesota tax credit to benefit early-stage companies

This article was originally published in The Gray Sheet

Executive Summary

Minnesota companies and investors will be able to apply for a new 25% angel investor tax credit by late summer. Gov. Tim Pawlenty signed the credit into law on April 1, implementing a policy that industry trade group LifeScience Alley said is designed to improve access to early-stage funding. Minnesota and out-of-state investors are eligible. Qualifying companies must have received less than $2 million in private equity, have fewer than 25 employees and be less than 10 years old

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028762

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel